Integra LifeSciences (IART) Tops Q2 EPS by 7c, Revenues Beat; Raises FY19 EPS Guidance, Affirms FY19 Revenue Outlook

July 24, 2019 5:50 AM

Integra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.73, $0.07 better than the analyst estimate of $0.66. Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found